Ascendis Pharma A/S (ASND) Earnings Date & Reports

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ASND is expected to report earnings to fall 19.62% to -126 cents per share on September 09

Ascendis Pharma A/S ASND Stock Earnings Reports

Q2'25

Est.

$-1.27

Q1'25

Missed

by $0.11

Q4'24

Beat

by $0.34

Q3'24

Missed

by $0.18

Q2'24

Missed

by $0.45

The last earnings report on May 01 showed earnings per share of -158 cents, missing the estimate of -147 cents. With 456.53K shares outstanding, the current market capitalization sits at 11.14B.

View a ticker or compare two or three

Compare

ASND